UB386
TargetsAT2R
IndicationsPost-stroke pain
ClinicalCN - II
TherapeuticsNeurology; Anesthesiology
ModalitiesSmall Molecule
Exclusive Summary
- • Highly selective AT2R antagonist with strong preclinical efficacy in neuropathic pain and post-surgical pain.
- • Excellent safety & PK profile in Phase I study.
- • Superior efficacy vs. Dezocin & Flurbiprofen Axetil in minipig surgical pain model.
Asset Materials
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →